Johan A. van Zyl
Keine laufenden Positionen mehr
Karriereverlauf von Johan A. van Zyl
Ehemalige bekannte Positionen von Johan A. van Zyl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Stonehage Fleming Private Equity Ltd.
 Stonehage Fleming Private Equity Ltd. Investment ManagersFinance Stonehage Fleming Private Equity Ltd (Stonehage Fleming Private Equity) is a private equity subsidiary of Stonehage Fleming (UK) Ltd founded in 2000. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 14.10.2001 | 01.12.2009 |
BAC BV
 BAC BV Industrial MachineryProducer Manufacturing BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands. | Direktor/Vorstandsmitglied | 31.03.2010 | - |
Ausbildung von Johan A. van Zyl
| University of Stellenbosch | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 2 |
| Niederlande | 2 |
| Südafrika | 2 |
Operativ
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 2 |
| Producer Manufacturing | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Stonehage Fleming Private Equity Ltd.
Stonehage Fleming Private Equity Ltd. Investment ManagersFinance Stonehage Fleming Private Equity Ltd (Stonehage Fleming Private Equity) is a private equity subsidiary of Stonehage Fleming (UK) Ltd founded in 2000. The firm is headquartered in London, United Kingdom. | Finance |
BAC BV
BAC BV Industrial MachineryProducer Manufacturing BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands. | Producer Manufacturing |
- Börse
- Insiders
- Johan A. van Zyl
- Erfahrung
